fecal
microbi
transplant
fmt
treatment
certain
gastrointestin
condit
associ
dysbiosi
peopl
also
empir
employ
hors
coliti
studi
use
microbiota
highthroughput
sequenc
compar
fecal
microbi
profil
healthi
hors
geriatr
microbi
transplant
recipi
experienc
diarrhea
test
whether
fmt
restor
microbiota
divers
evalu
effect
environ
donor
characterist
intestin
microbiota
fecal
sampl
collect
per
rectum
healthi
youngadult
year
geriatr
year
hors
addit
fmt
perform
consecut
day
geriatr
hors
diarrhea
use
fece
healthi
donor
fecal
sampl
collect
donor
recipi
prior
fmt
recipi
hour
follow
last
fmt
profil
fecal
bacteri
microbiota
compar
use
amplicon
sequenc
intestin
microbiom
imbal
dysbiosi
key
factor
develop
diarrhea
equin
coliti
remain
lead
caus
critic
ill
hors
estim
diseas
fatal
antibiot
therapi
often
ineffectu
even
worsen
diarrheal
diseas
destroy
benefici
commens
bacteria
gut
allow
pathogen
speci
expand
lack
specif
effect
therapi
equin
coliti
prevent
clinician
rapidli
revers
diseaseassoci
fluid
loss
system
inflamm
increas
complic
rate
result
need
intens
care
throughout
prolong
hospit
stay
earli
therapeut
intervent
therefor
necessari
circumv
potenti
lifethreaten
complic
coliti
sever
fluid
loss
lamin
coagulopathi
cardiovascular
dysfunct
improv
overal
outcom
specif
caus
coliti
remain
unknown
case
addit
bacteri
viral
infect
disrupt
delic
microbi
balanc
gut
dysbiosi
may
result
coliti
may
diminish
resist
enter
pathogen
emerg
data
suggest
fecal
microbi
transplant
fmt
may
efficaci
restor
normalci
gut
fmt
constitut
transfer
suspens
fecal
microorgan
healthi
donor
hors
intestin
tract
recipi
hors
order
treat
specif
diseas
associ
intestin
microbiom
imbal
may
thu
repres
novel
costeffect
therapi
success
restor
gut
function
hors
coliti
diarrhea
recent
shown
fecal
bacteri
microbiota
hors
coliti
variou
etiolog
less
divers
unaffect
anim
hors
acut
chronic
diarrhea
human
may
also
associ
intestin
dysbiosi
consist
import
balanc
intestin
microbiota
antibiot
therapi
inadequ
treatment
human
coliti
due
specif
pathogen
clostridium
difficil
welldescrib
clinic
trial
human
refractori
chronic
c
difficil
diarrhea
show
effect
one
fmt
effect
two
fmt
comparison
standard
treatment
vancomycin
recent
studi
mice
demonstr
autolog
fmt
significantli
enhanc
fecal
gastrointestin
microbiota
reconstitut
mice
follow
antimicrobi
treatment
similarli
anecdot
inform
aris
small
number
hors
suggest
fecal
consist
normal
follow
fmt
chronic
diarrhea
may
improv
respons
microbi
transplant
develop
fmt
inexpens
effect
mean
restor
colon
microbiota
therebi
combat
equin
coliti
would
benefit
veterinari
equin
industri
leverag
protect
properti
normal
gut
microbiota
treatment
modal
may
also
counteract
everincreas
problem
antibioticresist
microbi
pathogen
recent
studi
show
outcom
coliti
less
favor
geriatr
compar
younger
hors
time
popul
geriatr
hors
north
america
steadili
increas
aphi
nearli
increas
geriatr
hors
admiss
period
year
author
referr
institut
equin
geriatr
medicin
therefor
gain
rise
import
hors
veterinari
industri
consensu
age
impact
equin
gut
microbiota
hors
recoveri
condit
associ
dysbiosi
reach
date
conflict
associ
age
microbiota
divers
report
current
studi
therefor
investig
elig
geriatr
hors
fmt
donor
respons
geriatr
hors
fmt
treatment
although
recent
studi
improv
understand
equin
gut
microbiota
littl
known
effect
fmt
either
recipi
fecal
microbiota
mechan
lead
improv
clinic
outcom
current
studi
conduct
within
ethic
constraint
govern
use
client
hors
design
identifi
desir
fmt
donor
characterist
base
impact
age
diet
hous
normal
equin
fecal
microbiota
explor
shortterm
effect
fmt
microbiota
divers
geriatr
hors
coliti
studi
approv
cum
school
veterinari
medicin
institut
anim
care
use
committe
clinic
studi
review
committe
met
requir
ethic
care
treatment
anim
thirti
clinic
healthi
hors
two
age
group
youngadult
year
old
geriatr
hors
year
old
select
hous
facil
locat
massachusett
connecticut
base
avail
phenotyp
match
young
age
hors
locat
exposur
compar
diet
similar
manag
latter
select
criteria
use
determin
manag
phenotyp
featur
may
contribut
differ
fecal
microbiota
healthi
hors
thu
consid
select
donor
fecal
microbi
transplant
prior
fecal
collect
complet
diet
histori
medic
histori
physic
examin
obtain
ensur
clinic
health
exclus
criteria
includ
recent
gastrointestin
ill
colic
diarrhea
transport
medic
treatment
dietari
supplement
probiot
breed
age
bodi
condit
score
heart
rate
respiratori
rate
rectal
temperatur
attitud
borborygmi
record
prior
manur
collect
fece
collect
per
rectum
use
clean
glove
hand
two
separ
timepoint
week
apart
store
subsequ
analysi
experiment
design
method
approv
clinic
studi
review
committe
inform
client
consent
obtain
hors
quantit
fecal
egg
count
equin
diarrhea
pcr
panel
coronaviru
clostridium
difficil
toxin
b
clostridium
perfringen
antigen
lawsonia
intracellulari
neorickettsia
risticii
salmonella
sp
equin
diarrhea
panel
research
diagnost
core
facil
univers
california
davi
confirm
neg
control
hors
serv
fmt
donor
clinic
ill
geriatr
patient
diarrhea
prior
fmt
consecut
day
fecal
sampl
obtain
donor
manur
pile
subsequ
process
use
transfaun
singl
patient
donor
sampl
obtain
day
transfaun
store
sequenc
individu
thu
analyz
total
fmt
sampl
per
donor
obtain
consecut
day
administ
singl
recipi
five
geriatr
hors
hospit
tuft
cum
school
veterinari
medicin
diarrhea
pud
wateri
consist
serv
fecal
transplant
recipi
exclus
criteria
includ
histori
gastrointestin
reflux
within
day
prior
enrol
studi
follow
clinic
data
obtain
signal
present
complaint
predispos
factor
antibiot
nonsteroid
antiinflammatori
therapi
recent
longdist
travel
anesthesia
feed
chang
prior
enter
treatment
miner
oil
surfact
cathart
durat
diarrhea
develop
complic
lamin
thrombophleb
length
hospit
outcom
frequenc
diarrhea
hospit
record
everi
hour
clinic
patient
coliti
hors
diarrhea
qualiti
describ
everi
hour
scale
accord
follow
guidelin
firm
moist
ball
manur
softform
ball
manur
lose
form
upon
reach
ground
manur
still
hold
shape
manur
spread
upon
reach
ground
manur
form
piec
manur
without
form
piec
five
clientown
geriatr
hors
year
old
present
coliti
develop
diarrhea
inhospit
reason
receiv
fecal
microbi
transplant
singl
donor
hors
consecut
day
fmt
perform
use
standard
clinic
techniqu
short
pound
fresh
manur
collect
mix
liter
lukewarm
water
within
bouffant
cap
serv
standard
siev
mckesson
dispos
bouffant
cap
minut
mixtur
subsequ
strain
administ
within
minut
process
via
nasogastr
tube
recipi
hors
hors
check
reflux
use
l
water
prior
administr
fmt
l
net
reflux
consid
accept
ml
fecal
sampl
collect
per
rectum
recipi
prior
fmt
day
hour
follow
last
fmt
day
tabl
sampl
store
clinic
data
present
descript
mean
standard
deviat
sd
median
interquartil
rang
iqr
rang
univari
statist
analys
base
normal
data
distribut
shapirowilk
test
employ
independ
sampl
ttest
mannwhitney
u
chisquar
analys
compar
data
geriatr
youngadult
donor
hors
accept
signific
level
p
numer
analys
perform
ibm
spss
statist
packag
procedur
dna
extract
amplicon
librari
construct
bioinformat
previous
describ
briefli
fecal
dna
pcr
amplifi
prepar
amplicon
variabl
region
bacteri
rrna
gene
multiplex
amplicon
librari
sizeselect
pippin
ht
system
sage
bioscienc
beverli
massachusett
sequenc
illumina
miseq
sequenc
tuft
univers
genom
core
facil
tucf
org
use
singleend
strategi
control
technic
variat
introduc
pcr
librari
prepar
sequenc
librari
includ
two
replic
randomli
select
sampl
replic
involv
separ
process
subsampl
sampl
tag
amplicon
differ
barcod
fastq
format
sequenc
process
use
program
found
mothur
essenti
describ
briefli
random
subsampl
sequenc
per
sampl
process
pairwis
weight
unifrac
phylogenet
distanc
sampl
calcul
mothur
use
program
unifracweight
unifrac
distanc
rang
ident
sampl
sampl
complet
differ
share
sequenc
taxa
genalex
use
draw
princip
coordin
analysi
pcoa
plot
use
weight
unifrac
distanc
matric
input
analysi
similar
anosim
use
test
signific
cluster
treatment
program
anosim
run
mothur
use
weight
unifrac
distanc
matric
input
oper
taxonom
unit
otu
obtain
use
program
cluster
opticlust
cluster
method
distanc
cutoff
appli
linear
discrimin
analysi
lda
implement
program
lefs
use
identifi
statist
signific
differ
otu
abund
profil
two
group
sampl
defin
dietari
treatment
shannon
divers
also
calcul
mothur
constrain
ordin
analysi
perform
canoco
sequenc
data
access
number
sequenc
data
deposit
sequenc
read
archiv
studi
access
number
fecal
sampl
obtain
pair
youngadult
median
age
year
geriatr
hors
median
age
year
expos
compar
manag
condit
includ
mare
geld
age
youngadult
hors
match
base
phenotyp
bodi
condit
score
sex
diet
except
one
hors
pair
young
geld
match
age
mare
tabl
common
breed
includ
morgan
thoroughbr
western
breed
hors
neither
baselin
physic
examin
paramet
bodi
condit
score
differ
significantli
agegroup
p
hors
fed
median
bodi
weight
first
cut
hay
per
day
except
one
younggeriatr
hors
pair
receiv
bodi
weight
second
cut
hay
per
day
amount
concentr
fed
durat
pastur
turnout
differ
young
age
hors
p
tabl
five
geriatr
year
age
clientown
hors
includ
geld
mare
present
coliti
develop
diarrhea
hospit
prior
receiv
consecut
daili
fmt
singl
donor
durat
hospit
rang
day
hors
surviv
discharg
hors
histor
clinic
hematolog
characterist
specifi
tabl
hors
underw
salmonella
polymeras
chain
reaction
pcr
test
sampl
collect
hour
interv
combin
equin
diarrhea
pcr
panel
perform
hors
diarrhea
equin
diarrhea
panel
research
diagnost
core
facil
univers
california
davi
coronaviru
clostridium
difficil
toxin
b
clostridium
perfringen
cp
antigen
cp
alpha
toxin
cp
beta
toxin
cp
toxin
cp
cytotoxin
netf
cp
enterotoxin
lawsonia
intracellulari
neorickettsia
risticii
salmonella
identifi
potenti
etiolog
coliti
although
one
hors
f
test
posit
clostridium
perfringen
antigen
hors
like
experienc
undifferenti
coliti
hors
h
diarrhea
pcr
panel
perform
show
evid
sand
enteropathi
base
abdomin
radiograph
remov
enter
sand
rectal
palpat
fecal
microbiota
hors
treat
fmt
highli
heterogen
pairwis
weight
unifrac
distanc
valu
sampl
sampl
x
recipi
mean
n
valu
compar
mean
pairwis
distanc
healthi
hors
n
comparison
healthi
diarrheic
hors
statist
highli
signific
mannwhitney
rank
sum
test
p
appar
fig
fecal
microbiota
fmt
recipi
differ
healthi
hors
cluster
sampl
group
also
statist
signific
anosim
r
p
due
rel
larg
phylogenet
distanc
microbiota
healthi
diarrheic
hors
datapoint
healthi
hors
fig
appear
compress
tight
cluster
examin
microbiota
healthi
hors
structur
heterogen
sampl
origin
healthi
anim
analyz
separ
pcoa
color
geograph
origin
fig
show
broad
overlap
datapoint
differ
locat
test
effect
locat
bo
rhf
um
uc
microbiota
reveal
signific
effect
anosim
r
p
tabl
fig
show
mean
phylumlevel
phylogeni
microbiota
sampl
repres
fig
group
accord
age
fmt
donorrecipi
statu
confirm
data
shown
fig
age
visibl
affect
equin
fecal
microbiota
wherea
presenc
diarrhea
phylogenet
profil
donor
microbiota
broadli
repres
found
healthi
anim
even
though
coliti
microbiota
divers
featur
share
microbiota
diarrheic
hors
rel
low
abund
verrucomicrobia
high
proteobacteria
abund
observ
anim
classifi
phylum
level
microbiota
taxonomi
fig
reveal
phylogeni
underli
observ
among
five
diarrheic
hors
appar
fig
microbiota
three
hors
improv
diarrhea
score
hors
c
h
tabl
appear
respond
treatment
surviv
discharg
character
diminish
proteobacteria
abund
increas
abund
verrucomicrobia
appar
common
profil
microbiota
two
nonsurviv
hors
hors
f
w
fig
microbiota
hors
f
domin
proteobacteria
specif
enterobacterial
particularli
abund
within
order
sequenc
classifi
genu
trabulsiella
contrast
w
microbiota
domin
bacteroidet
mostli
order
bacteroidal
hors
w
ultim
diagnos
enterolithiasi
hors
f
treat
broadspectrum
antimicrobi
throughout
studi
period
penicilin
g
potassium
iukg
intraven
everi
hour
pfizerpen
pfizer
new
york
ny
enrofloxacin
mgkg
intraven
everi
hour
baytril
bayer
shawne
ks
begin
hour
prior
first
sampl
fmt
hors
also
receiv
one
inject
plot
base
weight
pairwis
unifrac
distanc
sampl
distanc
point
approxim
represent
phylogenet
distanc
microbiota
sampl
circl
sampl
healthi
old
n
young
n
hors
blue
circl
old
red
circl
young
red
triangl
fmt
donor
blue
triangl
fmt
recipi
http
oxytetracyclin
mgkg
intraven
refer
veterinarian
day
prior
hospit
admiss
fmt
recipi
expos
system
enter
antimicrobi
addit
increas
verrucomicrobia
abund
mention
two
chang
observ
hors
c
h
experienc
improv
diarrhea
score
treatment
surviv
discharg
increas
decreas
donor
microbiota
chang
microbiota
fmt
day
illustr
fig
regardless
trend
toward
higher
anim
microbiota
divers
fmt
recipi
remain
low
compar
microbiota
divers
healthi
hors
differ
appar
compar
rang
shannon
divers
valu
fig
fig
decreas
phylogenet
distanc
donor
recipi
characterist
microbiota
surviv
hors
diminish
sever
diarrhea
illustr
fig
pcoa
show
last
sampl
collect
day
fmt
semifil
circl
resembl
close
donor
donor
b
compar
earlier
sampl
collect
day
recipi
donor
hors
microbiota
hors
f
w
show
pattern
hors
receiv
fmt
donor
hors
f
w
transplant
similar
microbiom
fig
rel
low
unifrac
distanc
two
fmt
group
sampl
donor
transplant
given
day
two
recipi
rel
effect
donor
day
transplant
investig
canon
correspond
analysi
use
recipi
day
respect
independ
variabl
appar
fig
infer
fig
transplant
recipi
visibl
impact
microbiota
comparison
individu
otu
profil
vari
much
four
day
sampl
appar
larg
number
otu
present
similar
abund
time
fig
suggest
verrucomicrobia
abund
increas
diarrhea
score
diminish
chang
rel
abund
verrucomicrobia
treatment
surviv
hors
experienc
diminish
diarrhea
analyz
assess
whether
variabl
statist
correl
fig
correl
variabl
found
signific
hors
c
h
p
signific
third
p
datapoint
analyz
togeth
p
fecal
microbi
transplant
fmt
associ
improv
diarrhea
score
small
group
surviv
hors
present
acut
progress
diarrhea
referr
center
specif
increas
abund
verrucomicrobia
increas
observ
treatment
respond
latter
group
establish
microbiom
close
resembl
donor
hors
follow
consecut
daili
fecal
transplant
studi
diminish
unifrac
distanc
time
donor
fmt
recipi
suggest
transplant
bacteria
colon
gastrointestin
tract
recipi
hors
normal
intestin
microbiom
reestablish
healthi
gut
microbiom
hors
coliti
consid
essenti
digest
expect
act
bulwark
pathogen
bacteria
may
stimul
develop
robust
effect
immun
system
counteract
infect
addit
normal
microbi
inhabit
gut
thought
help
maintain
balanc
inflammatori
antiinflammatori
mediat
intestin
tract
may
stimul
mucu
product
prevent
attach
pathogen
bacteria
observ
increas
rel
abund
mucusdwel
verrucomicrobia
consist
increas
mucu
product
serv
barrier
pathogen
fmt
could
aid
restor
gut
function
hors
coliti
resolut
diarrhea
fecal
microbiom
hors
surviv
discharg
show
significantli
higher
higher
speci
rich
fmt
treatment
consid
treatment
respond
bacteri
speci
rich
divers
import
element
healthi
intestin
microbiom
reduct
rich
divers
associ
condit
chronic
diarrhea
recurr
c
difficil
infect
cdi
human
moreov
fmt
shown
highli
effect
treat
recurr
clostridium
difficil
infect
peopl
similar
data
veterinari
speci
less
abund
date
fmt
also
associ
faster
resolut
parvovirusassoci
diarrhea
puppi
compar
standard
treatment
therefor
fmt
establish
divers
microbiom
hors
coliti
procedur
may
repres
costeffect
therapi
facilit
restor
gut
function
hors
dysbiosi
coliti
anecdot
report
previous
suggest
fecal
consist
may
normal
follow
fmt
hors
chronic
diarrhea
may
improv
respons
microbi
transplant
recent
studi
evalu
efficaci
fmt
treatment
hors
chronic
increas
free
fecal
water
show
improv
fecal
consist
day
post
fmt
persist
throughout
entir
studi
period
day
contrast
coliti
free
fecal
water
syndrom
ffw
condit
recogn
hors
normal
fece
freeli
pass
fecal
liquid
defec
emerg
data
therefor
support
potenti
efficaci
fmt
restor
eubiosi
gut
hors
similar
observ
peopl
dog
predomin
phyla
identifi
fecal
microbiom
healthi
hors
current
studi
includ
bacteroid
firmicut
similar
previou
observ
costa
morrison
addit
verrucomicrobia
see
fig
contrast
rel
low
abund
verrucomicrobia
note
diarrheic
hors
invers
correl
diarrhea
score
rel
verrucomicrobia
abund
mucusdwel
bacteria
primarili
resid
intestin
mucosa
believ
contribut
intestin
health
glucos
homeostasi
previou
equin
work
demonstr
hors
coliti
may
also
show
decreas
firmicut
actinobacteria
spirochet
increas
fusobacteria
fecal
microbiom
fmt
recipi
current
report
differ
significantli
healthi
hors
high
diarrheic
hors
exampl
appar
common
microbiom
nonsurviv
hors
respond
fmt
hors
f
w
fig
indic
differ
etiolog
coliti
microbiom
hors
f
extrem
rich
proteobacteria
genu
trabulsiella
featur
observ
second
nonrespond
hors
w
firmicut
underrepres
w
microbiom
increas
verrucomicrobia
abund
observ
hors
follow
fmt
fig
hors
w
ultim
diagnos
enterolithiasi
hors
f
treat
broadspectrum
antimicrobi
throughout
studi
period
wherea
fmt
recipi
expos
system
enter
antimicrobi
well
establish
hors
system
antimicrobi
lead
chang
intestin
microbiota
differ
specif
respons
differ
antimicrobi
whether
fmt
mitig
revers
intestin
dysbiosi
face
concurr
antimicrobi
administr
establish
date
recent
studi
author
institut
show
outcom
coliti
less
favor
geriatr
compar
youngadult
hors
admit
referr
center
increas
patient
mortal
everi
year
hors
age
effect
treatment
coliti
geriatr
hors
thu
remain
particularli
challeng
optim
fmt
protocol
age
hors
fecal
microbiom
healthi
geriatr
youngadult
hors
compar
determin
util
geriatr
hors
fmt
donor
geriatr
age
donor
hors
year
old
significantli
affect
equin
fecal
microbiom
popul
healthi
hors
screen
studi
contrast
previou
report
document
inconsist
effect
advanc
age
equin
intestin
microbiom
invers
direct
relationship
observ
age
fecal
microbi
divers
current
studi
suggest
agematch
donor
fmt
recipi
requir
optim
microbi
transplant
adult
hors
howev
advanc
age
gener
associ
higher
incid
agerel
health
condit
reduc
risk
donor
comorbid
individu
age
year
prefer
human
fecal
donor
base
recent
consensu
confer
fecal
microbiom
transplant
peopl
similar
consider
may
appli
hors
reiter
need
establish
standard
protocol
optim
effect
fmt
clinic
practic
exampl
choos
donor
recipi
receiv
similar
diet
may
essenti
agematch
restor
intestin
eubiosi
adult
hors
coliti
expect
document
diet
affect
fecal
microbiom
healthi
donor
hors
healthi
fecal
donor
sampl
collect
studi
locat
close
geograph
proxim
sinc
differ
locat
also
differ
diet
feasibl
fulli
assess
impact
diet
fecal
microbiom
studi
locat
uc
site
hors
access
pastur
consist
strong
effect
diet
equin
fecal
microbiom
observ
other
microbiom
sampl
uc
significantli
differ
site
pairwis
anosim
test
tabl
access
pastur
report
increas
microbiom
divers
broad
spectrum
factor
known
affect
equin
intestin
microbiom
includ
feed
environment
condit
eg
geograph
locat
climat
hygien
fast
transport
exercis
inflamm
use
extern
compound
prebiot
probiot
antibiot
observ
support
effect
diet
therapeut
impact
fmt
consid
exampl
greater
abund
bacilluslactobacillusstreptococcu
bl
group
bacteria
previous
report
hors
maintain
concentr
diet
versu
grassonli
diet
predict
variabl
fmt
effect
may
base
fecal
donor
sourc
futur
research
aim
better
understand
associ
donor
microbiom
divers
effect
fmt
thu
consid
endpoint
research
would
identif
minim
set
bacteri
speci
could
combin
optim
synthet
probiot
prepar
overal
preliminari
work
support
fmt
mechan
establish
divers
microbiom
hors
coliti
may
thu
repres
costeffect
therapi
facilit
restor
gut
function
hors
dysbiosi
coliti
surviv
hors
respond
fmt
diminish
diarrhea
score
studi
like
improv
alpha
divers
increas
abund
verrucomicrobia
acquir
microbiom
began
resembl
donor
hors
howev
larger
casecontrol
studi
need
ensur
reliabl
result
fecal
microbiom
assess
healthi
geriatr
youngadult
hors
suggest
agematch
donor
fmt
recipi
necessari
optim
microbi
transplant
adult
hors
dietmatch
may
prudent
support
inform
distanc
triangl
approxim
averag
dissimilar
otu
composit
ie
bacteri
microbiota
taxonomi
maxim
clariti
otu
display
distanc
pie
symbol
approxim
dissimilar
rel
abund
otu
across
fecal
sampl
overlap
otu
otu
close
proxim
tend
occur
togeth
sampl
segment
pie
symbol
repres
otu
rel
abund
sampl
collect
hors
indic
color
fig
instanc
pie
blue
repres
otu
occur
fmt
recipi
h
otu
distribut
pattern
show
recipi
spite
show
similar
microbiota
pattern
like
increas
alphadivers
time
fig
popul
differ
microbiota
right
fmt
day
repres
red
triangl
pie
symbol
repres
otu
pie
segment
repres
otu
rel
abund
sampl
collect
fmt
day
indic
whitetoblack
shade
white
day
light
grey
day
dark
grey
day
black
day
distanc
pie
symbol
triangl
show
rel
abund
otu
individu
fmt
day
word
otu
predict
abund
fmt
day
locat
shortest
distanc
plot
addit
explan
see
left
panel
legend
tiff
